Kala Bio (KALA) Change in Inventory (2018 - 2023)
Kala Bio (KALA) posted Change in Inventory of -$5.2 million for Q3 2023, down 4624.32% sequentially from -$111000.0 in Q2 2023, and down 815.18% YoY from $733238.7 in Q3 2022.
Kala Bio (KALA) Change in Inventory (2018 - 2023) Analysis & Trends
Kala Bio has reported Change in Inventory for 6 years, with the latest figure at -$5.2 million in Q3 2023.
- Quarterly Change in Inventory fell 815.18% year-over-year to -$5.2 million in Q3 2023, while the trailing twelve-month figure through Dec 2023 was -$7.5 million (down 341.69% YoY) and the FY2023 annual result came in at -$7.5 million, down 341.69% from the prior year.
- Change in Inventory declined to -$5.2 million in Q3 2023 per KALA's latest filing, from -$111000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $2.9 million in Q2 2019 and troughed at -$5.2 million in Q3 2023.
- A 5-year average of $191789.5 and a median of $424000.0 in 2019 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2021 and 2023: Change in Inventory surged 1083.76% in 2021, then slumped 1434.76% in 2023.
- Over 5 years, Change in Inventory stood at -$108000.0 in 2019, then jumped by 975.0% to $945000.0 in 2020, then tumbled by 154.5% to -$515000.0 in 2021, then tumbled by 427.96% to -$2.7 million in 2022, then tumbled by 92.87% to -$5.2 million in 2023.
- According to Business Quant data, Change in Inventory over the past three periods registered -$5.2 million, -$111000.0, and -$2.2 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kala Bio | 9.89 Mn | 9.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -5.24 Mn |
| Sep 30, 2023 | -5.24 Mn |
| Jun 30, 2023 | -111,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | -2.19 Mn |
| Mar 31, 2023 | -2.19 Mn |
| Dec 31, 2022 | -2.72 Mn |
| Dec 31, 2022 | -2.72 Mn |
| Sep 30, 2022 | -573,000.00 |
| Sep 30, 2022 | -573,000.00 |
| Jun 30, 2022 | 1.42 Mn |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 164,000.00 |
| Mar 31, 2022 | 164,000.00 |
| Dec 31, 2021 | -515,000.00 |
| Dec 31, 2021 | -515,000.00 |
| Sep 30, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 2.58 Mn |